Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
SMT201500158B - Pellet farmaceutico di fattore di crescita epidermico somministrabile oralmente - Google Patents
[go: Go Back, main page]

SMT201500158B - Pellet farmaceutico di fattore di crescita epidermico somministrabile oralmente - Google Patents

Pellet farmaceutico di fattore di crescita epidermico somministrabile oralmente

Info

Publication number
SMT201500158B
SMT201500158B SM201500158T SM201500158T SMT201500158B SM T201500158 B SMT201500158 B SM T201500158B SM 201500158 T SM201500158 T SM 201500158T SM 201500158 T SM201500158 T SM 201500158T SM T201500158 B SMT201500158 B SM T201500158B
Authority
SM
San Marino
Prior art keywords
growth factor
epidermal growth
pharmaceutical pellet
oral epidermal
factor pharmaceutical
Prior art date
Application number
SM201500158T
Other languages
English (en)
Italian (it)
Inventor
Gomez Raimundo Ubieta
Barreto Ana Aguilera
Diaz Eduardo Martinez
Meireles Rolando Paez
Guerra Antonio Sereno
Original Assignee
Ct Ingenieria Genetica Biotech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ct Ingenieria Genetica Biotech filed Critical Ct Ingenieria Genetica Biotech
Publication of SMT201500158B publication Critical patent/SMT201500158B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5026Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18Growth factors; Growth regulators
    • A61K38/1808Epidermal growth factor [EGF] urogastrone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SM201500158T 2010-02-12 2015-07-03 Pellet farmaceutico di fattore di crescita epidermico somministrabile oralmente SMT201500158B (it)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP10382033A EP2364690A1 (en) 2010-02-12 2010-02-12 Orally administrable pharmaceutical pellet of epidermal growth factor
EP11702645.0A EP2533758B1 (en) 2010-02-12 2011-02-10 Orally administrable pharmaceutical pellet of epidermal growth factor
PCT/EP2011/051918 WO2011098499A1 (en) 2010-02-12 2011-02-10 Orally administrable pharmaceutical pellet of epidermal growth factor

Publications (1)

Publication Number Publication Date
SMT201500158B true SMT201500158B (it) 2015-09-07

Family

ID=42355395

Family Applications (1)

Application Number Title Priority Date Filing Date
SM201500158T SMT201500158B (it) 2010-02-12 2015-07-03 Pellet farmaceutico di fattore di crescita epidermico somministrabile oralmente

Country Status (21)

Country Link
US (1) US9205130B2 (sr)
EP (2) EP2364690A1 (sr)
JP (1) JP5778184B2 (sr)
KR (1) KR101745750B1 (sr)
CN (1) CN102753146B (sr)
AR (1) AR080144A1 (sr)
AU (1) AU2011214421B8 (sr)
BR (1) BR112012020223B8 (sr)
CA (1) CA2789055C (sr)
DK (1) DK2533758T3 (sr)
ES (1) ES2537704T3 (sr)
HR (1) HRP20150643T1 (sr)
HU (1) HUE024986T2 (sr)
MX (1) MX2012009217A (sr)
PL (1) PL2533758T3 (sr)
PT (1) PT2533758E (sr)
RS (1) RS54098B1 (sr)
RU (1) RU2540503C2 (sr)
SI (1) SI2533758T1 (sr)
SM (1) SMT201500158B (sr)
WO (1) WO2011098499A1 (sr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102432737B (zh) * 2011-09-07 2015-02-25 张绍国 一种缓释肠溶丙烯酸树脂乳胶液及其制法
WO2014159609A1 (en) 2013-03-14 2014-10-02 Allergen Research Corporation Peanut formulations and uses thereof
CN109125283A (zh) * 2013-03-14 2019-01-04 艾慕恩治疗公司 用于口服脱敏的花生制剂的制备
US12433945B2 (en) 2018-08-16 2025-10-07 Société des Produits Nestlé S.A. Peanut oral immunotherapy with maintenance dose
US12226448B2 (en) 2018-12-20 2025-02-18 Société des Produits Nestlé S.A. Peanut oral immunotherapy dosing schedule for missed doses
CA3137295A1 (en) 2019-05-10 2020-11-19 Aimmune Therapeutics, Inc. Methods for improving the quality of life of a patient with a peanut allergy

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62149622A (ja) 1985-12-24 1987-07-03 Wakunaga Pharmaceut Co Ltd 腸機能改善剤
US4743679A (en) * 1986-02-24 1988-05-10 Creative Biomolecules, Inc. Process for producing human epidermal growth factor and analogs thereof
DE3778275D1 (de) * 1986-08-07 1992-05-21 Roehm Gmbh Verfahren zur herstellung eines redispergierbaren kunststoffpulvers.
JPH01246223A (ja) 1988-03-28 1989-10-02 Hitachi Chem Co Ltd 潰瘍治療剤
US5272135A (en) * 1991-03-01 1993-12-21 Chiron Ophthalmics, Inc. Method for the stabilization of methionine-containing polypeptides
WO1999030671A2 (en) * 1997-12-15 1999-06-24 Ron Eyal S Aspected particles for oral delivery
US20030104996A1 (en) * 2001-08-30 2003-06-05 Tiansheng Li L-methionine as a stabilizer for NESP/EPO in HSA-free formulations
CN1671410B (zh) 2002-06-21 2010-05-12 诺和诺德医疗保健公司 因子ⅶ多肽的稳定化固体组合物
WO2004024125A1 (en) 2002-09-16 2004-03-25 Wyeth Delayed release formulations for oral administration of a polypeptide therapeutic agent and methods of using same
DE10332160A1 (de) * 2003-07-15 2005-02-03 Röhm GmbH & Co. KG Multipartikuläre Arzneiform, enthaltend mucoadhaesiv formulierte Peptid- oder Protein-Wirkstoffe, sowie ein Verfahren zur Herstellung der Arzneiform
AR045068A1 (es) * 2003-07-23 2005-10-12 Univ Missouri Formulacion de liberacion inmediata de composiciones farmaceuticas
CA2548773A1 (en) 2003-12-16 2005-06-30 University Technologies International Inc. A treatment for necrotizing enterocolitis
WO2007095288A2 (en) * 2006-02-13 2007-08-23 Nektar Therapeutics Methionine-containing protein or peptide compositions and methods of making and using
MXPA06013015A (es) * 2006-11-09 2007-02-07 Gastronomia Molecular S A Nuevo proceso de elaboracion y estabilidad de un producto nutritivo de amaranto.
CN103599541A (zh) * 2008-09-10 2014-02-26 弗·哈夫曼-拉罗切有限公司 用于防止蛋白质氧化降解的组合物和方法

Also Published As

Publication number Publication date
CA2789055A1 (en) 2011-08-18
RU2012139030A (ru) 2014-03-20
WO2011098499A1 (en) 2011-08-18
JP2013519649A (ja) 2013-05-30
AR080144A1 (es) 2012-03-14
MX2012009217A (es) 2012-11-23
US20120308661A1 (en) 2012-12-06
PT2533758E (pt) 2015-08-26
BR112012020223A2 (pt) 2017-07-04
CN102753146A (zh) 2012-10-24
CA2789055C (en) 2017-07-18
HRP20150643T1 (hr) 2015-08-14
ES2537704T3 (es) 2015-06-11
AU2011214421B8 (en) 2014-01-30
AU2011214421A8 (en) 2014-01-30
HUE024986T2 (en) 2016-01-28
RU2540503C2 (ru) 2015-02-10
SI2533758T1 (sl) 2015-08-31
EP2533758B1 (en) 2015-04-08
PL2533758T3 (pl) 2015-10-30
EP2533758A1 (en) 2012-12-19
BR112012020223B1 (pt) 2021-05-11
KR20120114402A (ko) 2012-10-16
AU2011214421B2 (en) 2013-12-19
DK2533758T3 (da) 2015-06-22
KR101745750B1 (ko) 2017-06-09
CN102753146B (zh) 2014-11-26
EP2364690A1 (en) 2011-09-14
AU2011214421A1 (en) 2012-08-23
RS54098B1 (sr) 2015-10-30
US9205130B2 (en) 2015-12-08
JP5778184B2 (ja) 2015-09-16
BR112012020223B8 (pt) 2021-05-25

Similar Documents

Publication Publication Date Title
IL245328A0 (en) Pharmaceutical composition
IL226245A0 (en) History
EP3738544C0 (de) Dentalimplantat
GT201200303A (es) Formulaciones farmacéuticas
GB201010193D0 (en) Medicinal use
DK2525798T3 (da) Anæstetisk formulering
DK2652652T3 (da) Medikmentadministration
FI9350U1 (fi) Ravintoformulaatioita
SI2645992T1 (sl) Trdna oralna dozirna oblika z asimetrično obliko
IL232305B (en) Pharmacy preparations
GB2486567B (en) Pharmaceutical formulation
DK2542224T3 (da) Oral farmaceutisk sammensætning indeholdende dabigatranetexilat
SMT201500158B (it) Pellet farmaceutico di fattore di crescita epidermico somministrabile oralmente
BR112013008074A2 (pt) combinações farmacêuticas
HUE036784T2 (hu) Alisporivirt tartalmazó gyógyászati készítmények
SMT202200299T1 (it) Composto medicinale naturale
HRP20141173T1 (hr) Medikament koji sadrži miramistin
ZA201403347B (en) Oral care gels
FI9608U1 (fi) Formulaatiot
DK2598472T3 (da) Formuleringer
GB201012046D0 (en) Pharmaceutical formulations
GB201012047D0 (en) Pharmaceutical formulations
ES1076284Y (es) Profilactico oral femenino
IT1401468B1 (it) Contenitore per farmaci
GB201018760D0 (en) An oral dosage form